Latest Close
$1.63
News
ADTX
Aditxt, Inc. News
This news view pulls recent coverage and headlines tied to ADTX.
1y Change
-$42,712.38 (-100.00%)
Market Cap
$54,434.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026
Business Wire • May 14, 2026
Read articleDana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
Business Wire • Apr 20, 2026
Read articleAditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer
Business Wire • Mar 19, 2026
Read articleAditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
Business Wire • Mar 13, 2026
Read articleAditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026
Business Wire • Mar 5, 2026
Read article